Cargando…

Probiotic Engineering and Targeted Sonoimmuno‐Therapy Augmented by STING Agonist

Tumor targeting and effective immunomodulation are of critical significance during tumor treatment by sonodynamic therapy (SDT). Herein, the probiotic engineering of the clinically approved sonosensitizer (hematoporphyrin monomethyl ether (HMME)) is reported onto the probiotic bacterium Bifidobacter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Dan, Wang, Liying, Wang, Liping, An, Liwei, Huo, Minfeng, Xu, Huixiong, Shi, Jianlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353485/ https://www.ncbi.nlm.nih.gov/pubmed/35603970 http://dx.doi.org/10.1002/advs.202201711

Ejemplares similares

Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy
por: Ji, Penghao, et al.
Publicado: (2022)

Tumor-selective catalytic nanomedicine by nanocatalyst delivery
por: Huo, Minfeng, et al.
Publicado: (2017)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
por: Wu, You-tong, et al.
Publicado: (2022)

Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth
por: Ding, Chunyong, et al.
Publicado: (2023)

Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

Magnesium hexacyanoferrate nanocatalysts attenuate chemodrug-induced cardiotoxicity through an anti-apoptosis mechanism driven by modulation of ferrous iron
por: Huo, Minfeng, et al.
Publicado: (2022)

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
por: Sanchez Alberti, Andrés, et al.
Publicado: (2017)

Structural and Biological Evaluations of a Non-Nucleoside STING Agonist Specific for Human STING(A230) Variants
por: Tang, Zhichao, et al.
Publicado: (2023)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
por: Guerini, Danilo
Publicado: (2022)

Prolonged activation of innate immune pathways by a polyvalent STING agonist
por: Li, Suxin, et al.
Publicado: (2021)

Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy
por: Wang, Bin, et al.
Publicado: (2022)

Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
por: Duvall, Jeremy R., et al.
Publicado: (2023)

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
por: Leventhal, Daniel S., et al.
Publicado: (2020)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

Epigenetic state determines the in vivo efficacy of STING agonist therapy
por: Falahat, Rana, et al.
Publicado: (2023)

Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer
por: Zhang, Jibing, et al.
Publicado: (2023)

Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system
por: Zhu, Qingyuan, et al.
Publicado: (2021)

Computational study on new natural compound agonists of stimulator of interferon genes (STING)
por: Zhong, Sheng, et al.
Publicado: (2019)

Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Production by Enhancing the Activation of STING-TBK1 Signaling
por: Petcharat, Kanoktip, et al.
Publicado: (2023)

An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
por: Liu, Yang, et al.
Publicado: (2019)

Author Correction: Prolonged activation of innate immune pathways by a polyvalent STING agonist
por: Li, Suxin, et al.
Publicado: (2021)

Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice
por: Vassilieva, Elena V., et al.
Publicado: (2019)

STING agonist promotes CAR T cell trafficking and persistence in breast cancer
por: Xu, Nuo, et al.
Publicado: (2020)

Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
por: Boudreau, C. Elizabeth, et al.
Publicado: (2021)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
por: Stazzoni, Samuele, et al.
Publicado: (2022)

Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold
por: Liu, Dongyu, et al.
Publicado: (2023)

Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway
por: Lu, Xing, et al.
Publicado: (2023)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023)

Engineered probiotics
por: Ma, Junheng, et al.
Publicado: (2022)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

STING Targeting in Lung Diseases
por: de Moura Rodrigues, Dorian, et al.
Publicado: (2022)

Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
por: Zhan, Meixiao, et al.
Publicado: (2022)

STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy
por: Zhou, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_af6vc2ts66643nt2q9pg422ed1